iNtRON Biotechnology
Manufacturing · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Suite 1310 Building A 14 Galmachi-ro 288...Website
www.intodeworld.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About iNtRON Biotechnology
iNtRON Biotechnology specializes in immune and immunotherapeutic solutions, focusing on innovative applications of bacteriophages. Their product offerings include immune on/off switching drugs, immune regulators, and bacteriophage protein TLR agonists. The company aims to address infectious diseases and enhance cancer immunotherapy through their advanced technologies. iNtRON Biotechnology seeks partnerships for further innovation in the field.Explore more
Popular SearchesiNtRON Biotechnology InciNtODEWORLD IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is iNtRON Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if iNtRON Biotechnology had a recent Job posting/layoffs
Earning: See what the market has to say on iNtRON Biotechnology recently announced quarterly report
Funding: Get notified immidiatlly once iNtRON Biotechnology has new funding data
Check if iNtRON Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when iNtRON Biotechnology launches new products
Check out if iNtRON Biotechnology is spiking on competitors!
Website visits: Recent activity has been detected on your website
iNtRON Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at iNtRON Biotechnology
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to iNtRON Biotechnology
Compare insights from companies similar to iNtRON Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
iNtRON Biotechnology
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
iNtRON Biotechnology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
iNtRON Biotechnology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about iNtRON Biotechnology.
iNtRON Biotechnology Tech Stack
A closer look at the technologies used by iNtRON Biotechnology
iNtRON Biotechnology News & Media
iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology
▶ Robot Bacteriophage against microbiome associated with colorectal cancer ▶ Bacteriophage Improvement Platform technology with a broad antimicrobial activity ▶ Proprietary Technology incorporating CRISPR/Cas Technology BOSTON, Feb. 15, 2024 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that New Drug Part has secured a potent anti-cancer candidate, PHAGERIA®, with broad antimicrobial activity against ETBF (Enterotoxigenic B. fragilis), a harmful microbeiNtRON, Executes Evaluation License and Option Agreement for SAL200
iNtRON Grants Basilea exclusive right for preclinical evaluation with an undisclosed payment Basilea has the option to enter into exclusive License Agreement following the evaluation BOSTON and SEOUL, South Korea, Oct. 30, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",...iNtRON, Executes Evaluation License and Option Agreement for SAL200
iNtRON Grants Basilea exclusive right for preclinical evaluation with an undisclosed payment Basilea has the option to enter into exclusive License Agreement following the evaluation BOSTON and SEOUL, South Korea, Oct. 30, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that they have signed an "EVALUATION LICENSE AND OPTION AGREEMENT" with Basilea Pharmaceutica Ltd, Allschwil ("Basilea"), granting Basilea the option to enter into an exclusive licensiNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM
Development of Bacteriophages targeting strains causing urinary tract infections Establishment of collaboration with the US Army and investigation of groundwork for entering the US defense market BOSTON and SEOUL, South Korea, Sept. 3, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding iNtRON Biotechnology
Sign Up For FreeTo access detailed company insights
iNtRON Biotechnology specializes in immune and immunotherapeutic solutions, focusing on innovative applications of bacteriophages. Their product offerings include immune on/off switching drugs, immune regulators, and bacteriophage protein TLR agonists. The company aims to address infectious diseases and enhance cancer immunotherapy through their ad... Read More
